OR WAIT 15 SECS
Developer and supplier of film coating systems and excipients, Colorcon, has launched a new platform of on-dose technologies and detection services for the authentication of medications.
Developer and supplier of film coating systems and excipients, Colorcon, has launched a new platform of on-dose technologies and detection services for the authentication of medications, it was announced in a May 14, 2020 press release.
SoteriaRx uses a ‘lock and key mechanism,’ whereby the coated or printed dosage form becomes the ‘lock’ and the detection method is the ‘key’. The detection methods are unique taggants, which are specific to the customer and can be used on multiple drug products.
In the press release, Kelly Boyer, general manager, Film Coatings, said, “SoteriaRx on-dose authentication provides a powerful tool for tracking medicines from plant to patient and provides a level of supply chain authenticity and transparency not previously available. By incorporating microtags, the pill itself effectively becomes a barcode which can be digitally read and recorded, providing instant authentication.”
“The digitalization of medicines represents a major step forward in the fight against unauthorized and illegitimate pharmaceutical production and provides an opportunity to safeguard patients,” added Martti Hedman, CEO of Colorcon, in the press release. “This investment to bring on-dose authentication technology to market demonstrates Colorcon’s commitment to respond to the needs of the pharmaceutical industry by developing innovative solutions that are efficient to deliver and which offer dependable performance.”